Which of the following are among the treatment options for the patient with myasthenia gravis?
1. Pyridostigmine (Mestinon)
2. Plasmapheresis
3. Thymectomy
4. Mechanical ventilation
a. 1, 3
b. 2, 4
c. 1, 2, 4
d. 1, 2, 3, 4
Q. 2 The management of COPD may include:
1. annual influenza immunization.
2. bronchopulmonary hygiene procedures.
3. bronchodilators.
4. smoking cessation.
a. 1, 2
b. 2, 3
c. 2, 3, 4
d. 1, 2, 3, 4
Q. 3 The respiratory therapist is reviewing a patient's electronic medical record to try to verify if the patient has tissue hypoxia. Which of the following laboratory values is MOST likely to correlate with tissue hypoxia?
a. Metabolic acidosis
b. Thrombocytopenia
c. Hypokalemia
d. Bilirubinemia
Q. 4 Chest assessment findings in a patient with ILD would include:
1. pleural friction rub.
2. increased vocal fremitus.
3. vesicular breath sounds.
4. hyperresonant percussion note.
a. 1, 2
b. 2, 3
c. 1, 3, 4
d. 1, 2, 3, 4
Q. 5 Which of the following values would be associated with impending ventilatory failure in a patient with myasthenia gravis?
1. NIF 15cm H2O
2. VC 10 mL/kg
3. PaCO2 43 mm Hg
4. pH 7.36
a. 1
b. 1, 2
c. 2, 4
d. 1, 2, 3
Q. 6 What is the major anatomic pathology associated with new BPD?
a. Alveolar hypoplasia
b. Alveolar hyperplasia
c. Alveolar atelectasis
d. Alveolar-capillary wall thickening
Quick Reply
